Search results
Silo Pharma Concludes First Phase of Dose-Ranging Study Of Intranasal Treatment For Post Traumatic...
Benzinga via Yahoo Finance· 5 months agoThursday, Silo Pharma Inc (NASDAQ: SILO) provided an update on its previously announced dose-ranging...
Your Next COVID Booster Might Go Up Your Nose
The Daily Beast via Yahoo News· 1 year agocnsphoto via REUTERSThe nose knows, as the saying goes, and a new study suggests this may be the case for immunologic knowledge against the COVID-19...
Oragenics Looks To Boost Potency Of Its Nasal COVID-19 Vaccine With New Licensing Pact
Benzinga via Yahoo Finance· 1 year agoOragenics Inc (NYSE: OGEN) entered into an exclusive global license agreement with Inspirevax Inc...
A nasal vaccine could be key in curbing the spread of COVID-19
The Hill via Yahoo News· 2 years agoStory at a glance A nasal vaccine could be another weapon in the arsenal against COVID-19. Early...
Ocugen Inks US Development Pact For Its Intranasal COVID-19 Vaccine
Benzinga via Yahoo Finance· 2 years agoOcugen Inc (NASDAQ: OCGN) has entered into an exclusive license agreement with Washington University...
Revelation Biosciences Surges After Encouraging Data From Allergic Rhinitis Study
Benzinga via Yahoo Finance· 2 years agoRevelation Biosciences Inc (NASDAQ: REVB) announced topline data for its Phase 1b CLEAR study to...
Biden administration awards $500M for new COVID treatments
The Hill via Yahoo News· 7 months agoThe Department of Health and Human Services (HHS) on Friday announced it is awarding $500 million in...
Tiziana Life Sciences Posts Additional Clinical Improvements In Second Patient with Multiple...
Benzinga via Yahoo Finance· 1 year agoTiziana Life Sciences Ltd (NASDAQ: TLSA) announced that the second patient (EA2) with non-active...
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line
Politico via Yahoo News· 2 years agoBiden administration officials are raising concerns that the slow pace of developing a nasal vaccine...
Amphastar Pharmaceuticals Drug Stock Nears All-Time High After 74% Earnings Growth
Investor's Business Daily· 1 year agoAmphastar Pharmaceuticals develops, manufactures and markets injectable, intranasal and inhalation...